Literature DB >> 19968607

LUPP relieves partial upper airway obstruction during sleep in patients with velopharyngeal narrowing.

Perttu Halme1, Elina Toskala, Esa Laurikainen, Jukka Antila, Yoshito Tsushima, Olli Polo.   

Abstract

CONCLUSION: Patients with upper airway narrowing at the soft palate level and partial upper airway obstruction during sleep seem to benefit from laser-assisted uvulopalatoplasty (LUPP) in terms of decreased velopharyngeal collapsibility and improved nocturnal breathing.
OBJECTIVES: The current operative treatments for obstructive sleep apnea syndrome (OSAS) are not very effective compared with continuous positive airway pressure (CPAP). It has been suggested that active treatment should be performed earlier, when sleep apnea is present in a milder form. The main problem is identifying progressive sleep apnea. The present study assessed the efficacy of LUPP in patients with partial upper airway obstruction during sleep diagnosed by means of a static charge-sensitive bed (SCSB) combined with oxyhemoglobin desaturation recording and digital fluoroscopy-based collapsibility estimation.
METHODS: LUPP was carried out in 27 patients under local anesthesia as day surgery. Digital fluoroscopy and SCSB were recorded preoperatively and 6 months after LUPP.
RESULTS: Partial upper airway obstruction events and arterial oxyhemoglobin desaturations during sleep decreased significantly. Digital fluoroscopy revealed that the minimal anteroposterior dimension increased and collapsibility decreased at the level where velopharyngeal obstruction occurred, the soft palate.

Entities:  

Mesh:

Year:  2010        PMID: 19968607     DOI: 10.3109/00016480903311872

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

1.  The velo-uvulo-pharyngeal lift or "roman blinds" technique for treatment of snoring: a preliminary report.

Authors:  M Mantovani; A Minetti; S Torretta; A Pincherle; G Tassone; L Pignataro
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-02       Impact factor: 2.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.